Member-only story
Clinical Care of Cancer Patients in the Age of COVID
By Patricia Salber MD, MBA (@docweighsin)
Dr. Bobby Reddy discusses the impact of the COVID-19 pandemic on the care of cancer patients, including changes to treatment and way care is delivered.
Dr. Sandeep “Bobby” Reddy joined me on my podcast for the American Journal of Managed Care to discuss the clinical care of cancer patients in the age of COVID. Dr. Reddy is an oncologist at the UCLA School of Medicine and the Chief Medical Officer of NantHealth, a healthcare cloud-based information technology company that converges science and technology through a single integrated clinical platform.
What follows is a modified version of the transcript of the interview. It has been abbreviated and edited for readability. Some sections have been omitted altogether (e.g. growth factor use, and participation in clinical trials) but can be found on the podcast recording.
PS: Are cancer patients at increased risk to get COVID-19?
BR: It’s an interesting question, however, despite so many cases and so much time that’s elapsed, the answer, unfortunately, is we don’t really know.
What we do know is that cancer patients are at higher risk of mortality if they do contract the virus. And that is true for…
